Magaldrate and Simethicone are combined in an over-the-counter medication used to relieve symptoms of indigestion, heartburn, and bloating. Magaldrate is an antacid that neutralizes stomach acid, while Simethicone is an anti-foaming agent that reduces gas bubbles in the digestive tract.
The combination of Magaldrate and Simethicone is used to treat:
| Brand Name | Pepcon Plus |
|---|---|
| Type | Oral Suspension |
| Weight | (480 mg+20 mg)/5 ml |
| Generic | Magaldrate + Simethicone |
| Manufacturer | Leon Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Magaldrate acts as an antacid by neutralizing stomach acid, thereby reducing acidity in the stomach and upper gastrointestinal tract. This alleviates the symptoms of heartburn and indigestion. Simethicone works by reducing the surface tension of gas bubbles, causing them to coalesce and be more easily expelled from the digestive tract, which helps relieve bloating and discomfort.
Magaldrate begins to neutralize stomach acid almost immediately after ingestion, providing rapid relief from heartburn and acid indigestion. Simethicone works within 30 minutes to 1 hour to alleviate bloating and gas discomfort. Combined, the effects are generally felt within an hour of taking the medication.
Magaldrate does not significantly absorb into the bloodstream; it acts locally in the stomach. Simethicone also has minimal systemic absorption as it primarily acts in the gastrointestinal tract. Both components work locally rather than systemically.
Magaldrate is eliminated primarily through the feces as it remains in the gastrointestinal tract. Simethicone is also excreted in the feces after its action in the digestive tract. Both substances are not significantly metabolized or absorbed into the systemic circulation.
The typical dosage for Magaldrate and Simethicone combination products is:
Magaldrate and Simethicone are available in various forms, including chewable tablets, suspension (liquid), and soft gels. Administration typically involves:
Common side effects include:
Magaldrate and Simethicone have a low risk of toxicity when used as directed. Overuse or excessive doses may lead to gastrointestinal disturbances such as severe constipation or diarrhea. Chronic overuse of antacids like Magaldrate could potentially lead to imbalances in electrolytes or metabolic alkalosis.
Precautions should be taken in individuals with:
Magaldrate can interact with certain medications by altering the pH of the stomach or affecting their absorption. It may reduce the effectiveness of:
Caution is advised in patients with:
Magaldrate can interact with:
No specific food interactions have been noted with Magaldrate and Simethicone. However, it is generally recommended to avoid excessive consumption of foods that may exacerbate indigestion or gas, such as fatty, spicy, or carbonated foods.
Magaldrate and Simethicone are classified as pregnancy category A for antacids, meaning they are generally considered safe for use during pregnancy. However, it is always advisable to consult a healthcare provider before using any medication during pregnancy.
Magaldrate and Simethicone are considered safe for use during breastfeeding, as they are minimally absorbed into the systemic circulation. It is still recommended to consult a healthcare provider before using these medications while breastfeeding.
Acute overdose of Magaldrate and Simethicone is unlikely but could lead to gastrointestinal disturbances such as severe constipation or diarrhea. Treatment involves symptomatic management and discontinuation of the medication. In severe cases, medical evaluation may be required.
Magaldrate and Simethicone are contraindicated in:
Magaldrate and Simethicone should be used as follows:
Magaldrate and Simethicone should be stored at room temperature (15-30°C or 59-86°F), away from light and moisture. Keep the product tightly closed and out of reach of children. Do not freeze.
The volume of distribution for Magaldrate and Simethicone is not well-defined due to their local action and minimal systemic absorption.
Magaldrate and Simethicone do not have a defined half-life as they are not significantly absorbed into the bloodstream. Their effects are localized within the gastrointestinal tract.
Magaldrate and Simethicone are cleared primarily through the feces after their action in the gastrointestinal tract. Systemic clearance is minimal due to their low absorption into the systemic circulation.
See in details version Pepcon Plus Oral Suspension (480 mg+20 mg)/5 ml also Pepcon Plus Oral Suspension (480 mg+20 mg)/5 ml in bangla
Dr. Md. Anamur Rahman
Cardiology (Heart Diseases, Hypertension, Rheumatic Fever) Specialist